DD210029A5 - Verfahren zur herstellung von halogenophenylglycerid-estern - Google Patents

Verfahren zur herstellung von halogenophenylglycerid-estern Download PDF

Info

Publication number
DD210029A5
DD210029A5 DD83252126A DD25212683A DD210029A5 DD 210029 A5 DD210029 A5 DD 210029A5 DD 83252126 A DD83252126 A DD 83252126A DD 25212683 A DD25212683 A DD 25212683A DD 210029 A5 DD210029 A5 DD 210029A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
acid
esters
chloro
chlorine
Prior art date
Application number
DD83252126A
Other languages
German (de)
English (en)
Inventor
Jean-Claude Arnould
John R Evans
Geraint Jones
David S Thomson
Original Assignee
Ici Plc
Ici Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc, Ici Pharma filed Critical Ici Plc
Publication of DD210029A5 publication Critical patent/DD210029A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD83252126A 1982-06-18 1983-06-17 Verfahren zur herstellung von halogenophenylglycerid-estern DD210029A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP82401119 1982-06-18

Publications (1)

Publication Number Publication Date
DD210029A5 true DD210029A5 (de) 1984-05-30

Family

ID=8189916

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83252126A DD210029A5 (de) 1982-06-18 1983-06-17 Verfahren zur herstellung von halogenophenylglycerid-estern

Country Status (25)

Country Link
US (1) US4587262A (fr)
EP (1) EP0099177B1 (fr)
JP (1) JPS5951240A (fr)
KR (1) KR840005068A (fr)
AT (1) ATE21686T1 (fr)
AU (1) AU562207B2 (fr)
CA (1) CA1221983A (fr)
CS (2) CS241088B2 (fr)
DD (1) DD210029A5 (fr)
DE (1) DE3365634D1 (fr)
DK (1) DK278283D0 (fr)
ES (3) ES8500318A1 (fr)
FI (1) FI832227L (fr)
GB (1) GB8313634D0 (fr)
GR (1) GR79196B (fr)
HU (1) HU191531B (fr)
IE (1) IE55531B1 (fr)
IL (1) IL68950A (fr)
NO (1) NO832203L (fr)
NZ (1) NZ204625A (fr)
PH (1) PH20587A (fr)
PL (1) PL242535A1 (fr)
PT (1) PT76889B (fr)
ZA (1) ZA834135B (fr)
ZW (1) ZW12983A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8313634D0 (en) * 1982-06-18 1983-06-22 Ici Plc Halogenophenyl glyceride esters
US4642366A (en) * 1984-03-05 1987-02-10 Stauffer Chemical Company Process for preparing methyl phosphonamides
AU731832B2 (en) * 1996-11-12 2001-04-05 Tamarkin Pharmaceutical Innovation Ltd Method for treatment of dermatological disorders
DE60143052D1 (de) * 2000-11-10 2010-10-21 Univ Waseda Lipid vom carbonsäuretyp
FR2839448A1 (fr) * 2002-05-07 2003-11-14 Oreal Utilisation d'esters de triclosan, de piroctone et de tropolone dans une composition a liberation controlee
US8026285B2 (en) 2007-09-04 2011-09-27 Bezwada Biomedical, Llc Control release of biologically active compounds from multi-armed oligomers
US8048980B2 (en) 2007-09-17 2011-11-01 Bezwada Biomedical, Llc Hydrolysable linkers and cross-linkers for absorbable polymers
US8053591B2 (en) 2007-09-26 2011-11-08 Bezwada Biomedical, Llc Functionalized biodegradable triclosan monomers and oligomers for controlled release
EP2723452A2 (fr) 2011-06-22 2014-04-30 Vyome Biosciences Pvt Ltd Promédicaments antifongiques et antibactériens à base d'un conjugué
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
CN118063537A (zh) 2015-09-08 2024-05-24 莫纳什大学 定向淋巴的前药
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP4306524A3 (fr) 2017-08-29 2024-09-11 PureTech LYT, Inc. Promédicaments lipidiques dirigeant le système lymphatique
EP4262778A4 (fr) * 2020-12-21 2025-10-22 Univ New York State Res Found Agents de cryoprotection pénétrants et leurs procédés de fabrication et d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH406127A (de) * 1963-02-22 1966-08-15 Geigy Ag J R Verfahren zum antimikrobiellen Ausrüsten von Textilien
NL133434C (fr) * 1963-02-22 1972-02-15
US3506720A (en) * 1963-02-22 1970-04-14 Geigy Chem Corp Halogenated hydroxy-diphenyl ethers
GB1051823A (fr) * 1964-02-14
FR1441499A (fr) * 1964-02-14 1966-06-10 Geigy Ag J R Nouveaux esters phényliques doués de propriétés antimicrobiennes, utilisables en particulier pour la protection des matériaux organiques
GB8313634D0 (en) * 1982-06-18 1983-06-22 Ici Plc Halogenophenyl glyceride esters

Also Published As

Publication number Publication date
ES523376A0 (es) 1984-10-01
ATE21686T1 (de) 1986-09-15
ES8601295A1 (es) 1985-11-01
PT76889B (en) 1986-01-24
ES530745A0 (es) 1985-11-01
NZ204625A (en) 1985-10-11
FI832227A7 (fi) 1983-12-19
DE3365634D1 (de) 1986-10-02
JPS5951240A (ja) 1984-03-24
CA1221983A (fr) 1987-05-19
PH20587A (en) 1987-02-20
PL242535A1 (en) 1984-09-24
ES530744A0 (es) 1985-06-16
US4587262A (en) 1986-05-06
KR840005068A (ko) 1984-11-03
ZA834135B (en) 1984-04-25
NO832203L (no) 1983-12-19
EP0099177A1 (fr) 1984-01-25
IE55531B1 (en) 1990-10-24
ZW12983A1 (en) 1985-01-30
CS241088B2 (en) 1986-03-13
EP0099177B1 (fr) 1986-08-27
FI832227A0 (fi) 1983-06-17
IE831435L (en) 1983-12-18
AU1569883A (en) 1985-10-03
CS394384A2 (en) 1985-07-16
PT76889A (en) 1983-07-01
GB8313634D0 (en) 1983-06-22
CS241061B2 (en) 1986-03-13
DK278283D0 (da) 1983-06-16
FI832227L (fi) 1983-12-19
ES8505921A1 (es) 1985-06-16
HU191531B (en) 1987-03-30
CS445683A2 (en) 1985-07-16
GR79196B (fr) 1984-10-22
ES8500318A1 (es) 1984-10-01
AU562207B2 (en) 1987-06-04
IL68950A (en) 1988-05-31

Similar Documents

Publication Publication Date Title
DD151931A5 (de) Verfahren zur herstellung neuer polyolderivate
EP0465970A1 (fr) Pyrrolo-pyridines substituées
EP0099177B1 (fr) Esters halogénophényliques du glycérol
EP0029247A1 (fr) Acides alcényl-thiényl-alcane carboxyliques et leurs dérivés, procédé pour leur préparation et médicaments les contenant
DE2460990A1 (de) Neue prostaglandin-analoga und verfahren zu ihrer herstellung
DD210027B3 (de) Verfahren zur herstellung von carbacyclinderivaten
DE3714937A1 (de) Neue retinsaeureester von antibiotika, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen
DE2310141A1 (de) Verfahren zur herstellung von 1phenyl-2-aminoaethanolderivaten
DE2416978A1 (de) Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff
DE2437832C2 (de) Phospholipide, Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE3138063C2 (fr)
DE69500041T2 (de) Eine Urethangruppe enthaltende, fluorierte Alkylester, ihre Herstellung, ihre Verwendung als Verdickungsmittel in nicht wässrigen Medien, und diese enthaltende Medien und Zusammensetzungen
DE2946652A1 (de) Optisch aktive 4-phenoxyphenoxypropionsaeurederivate
EP0031426B1 (fr) Dérivés 7-oxo-PGI2, procédé pour leur préparation et compositions pharmaceutiques contenant ces composés
DE1293141B (de) Verfahren zur Herstellung von optisch aktiven Alkoholen
DE2903094A1 (de) Derivate der naphtyl-1-essigsaeure, verfahren zur herstellung und therapeutische anwendung derselben
DE4426267C2 (de) Verfahren zur enantioselektiven Synthese von pharmakologisch wirksamen Sesquiterpenen, Zwischenprodukt und Verfahren zu dessen Herstellung
DE2902809A1 (de) Neue analoga von prostacyclin
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga
DE4447594A1 (de) Neue pharmakologisch wirksame, enantiomere Sesquiterpene und pharmazeutische Zubereitungen, enthaltend diese Verbindungen
EP0080718B1 (fr) Dérivés inter-m-phénylène-PGI2, procédé pour leur préparation et compositions pharmaceutiques les contenant
CH640501A5 (de) Verfahren zur herstellung von pyrethrinen.
DE2807786C2 (fr)
DE2739770C3 (de) 19-Methyl-9-keto-15-hydroxy-prost-18-ensäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2217044C2 (de) Optisch aktive Prostaglandinderivate und deren racemische Gemische sowie Verfahren zu ihrer Herstellung